REG – Morgans rates the stock as Upgrade to Add
Morgans lifts the rating for Regis Healthcare to Add from Hold. The target price increases to $2.23 from $2.03.
Read More
Regis Healthcare Limited
Formed in 1994, Regis is one of Australia’s largest providers of aged care services with expertise and experience in all areas of aged care. Over 6,000 Australians, in all states and the Northern Territory, call Regis home.
With a focus on support and care for residents, Regis has set new benchmarks in aged care. And they constantly upgrade their facilities to meet or exceed the standards required of contemporary aged care.
Videos
Videos coming soon for Regis Healthcare Limited.
News
REG – Macquarie rates the stock as Upgrade to Outperform
Led by an improved funding outlook, Macquarie moves to Outperform from Neutral with the target rising to $2.95 from $2.1.
Read More
REG – UBS rates the stock as Neutral
First half results were broadly in line with UBS estimates. Average occupancy declined to 90.4%.
Read More
REG – UBS rates the stock as Buy
UBS assesses Regis Healthcare continues to generate the best returns in the aged care sector, with the highest quality portfolio of assets.
Read More
REG – UBS rates the stock as Buy
The company has reduced FY19 guidance, indicating net profit will now be at the lower end of $47-51m. New FY20 guidance, $105m in operating earnings (EBITDA) and $38m in net profit, is below UBS estimates.
Read More
Aged Care Moves Into The RC Spotlight
The Commonwealth government is proposing an inquiry into the Australian aged care sector and brokers suspect that prospect, and negative media coverage, will impact on listed stocks.
Read More
